Catalyst Wire Dossier Catalyst Wire Dossier

REGN7075

REGN7075 · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REGN7075, covering 2026-03-20 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers [Phase 1, Phase 2]

See pricing